BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23121546)

  • 41. β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
    Huang GL; Shen DY; Cai CF; Zhang QY; Ren HY; Chen QX
    World J Gastroenterol; 2015 Jan; 21(4):1148-57. PubMed ID: 25632187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.
    Kang MA; Kim JT; Kim JH; Kim SY; Kim YH; Yeom YI; Lee Y; Lee HG
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):761-9. PubMed ID: 19034516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
    Wu Z; Lu B; Li X; Miao W; Li J; Shi Y; Yu W
    Clin Exp Pharmacol Physiol; 2018 May; 45(5):444-451. PubMed ID: 29143362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.
    Sun Q; Zhao C; Xia L; He Z; Lu Z; Liu C; Jia M; Wang J; Niu J
    Int J Clin Exp Pathol; 2014; 7(9):6157-64. PubMed ID: 25337264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
    Jin J; Ryu HS; Lee KB; Jang JJ
    PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
    Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
    Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
    Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
    J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-expressed CKS2 is associated with hepatocellular carcinoma cell proliferation through down-regulating PTEN.
    Ji X; Xue Y; Wu Y; Feng F; Gao X
    Pathol Res Pract; 2018 Mar; 214(3):436-441. PubMed ID: 29487004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CKS1 Germ Line Exclusion Is Essential for the Transition from Meiosis to Early Embryonic Development.
    Ellederova Z; Del Rincon S; Koncicka M; Susor A; Kubelka M; Sun D; Spruck C
    Mol Cell Biol; 2019 Jul; 39(13):. PubMed ID: 30988159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.
    Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Ligand for peroxisome proliferator-activated receptor gamma inhibits human cholangiocarcinoma cell growth: potential molecular targeting strategy for cholangioma.
    Kobuke T; Tazuma S; Hyogo H; Chayama K
    Dig Dis Sci; 2006 Sep; 51(9):1650-7. PubMed ID: 16927143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.
    Yao L; Han C; Song K; Zhang J; Lim K; Wu T
    Cancer Res; 2015 Apr; 75(7):1388-98. PubMed ID: 25691459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
    Huang YC; Chen M; Shyr YM; Su CH; Chen CK; Li AF; Ho DM; Chen YM
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1384-9. PubMed ID: 18624901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma.
    Mo C; Wu Y; Ma J; Xie L; Huang Y; Xu Y; Peng H; Chen Z; Zeng M; Mao R
    BMC Med Genomics; 2022 Apr; 15(1):81. PubMed ID: 35410253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.
    Yang X; Wang S; Mu Y; Zheng Y
    Oncol Rep; 2016 Oct; 36(4):1799-806. PubMed ID: 27499090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
    Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
    Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.